Keyvan Mirsaeedi-Farahani

Keyvan Mirsaeedi-Farahani is a seasoned professional with extensive experience in both healthcare and business. Currently serving as a Board Member and Co-Founder at Neurosterix since March 2024, Keyvan has held the position of Managing Director for Therapeutics at Perceptive Advisors since June 2016. Keyvan previously contributed to groundbreaking research on Alzheimer’s disease and related areas as a Research Associate at Penn Medicine from 2011 to 2014. Keyvan's earlier experience includes roles at McKinsey & Company as both a Business Analyst and Summer Business Analyst, where problem-solving frameworks were developed and communicated to executive teams. Keyvan's educational background includes an MBA from Harvard Business School, an MD from the University of Pennsylvania Perelman School of Medicine, and dual degrees in Finance and Molecular Biology from the University of Michigan.